Skip to content

Drug interactions

Eliglustat + Terbinafine

Severity: Major

Eliglustat and Terbinafine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat is mainly metabolized by CYP2D6, and terbinafine strongly inhibits it. Raised eliglustat levels may prolong PR, QRS and QT intervals and cause arrhythmia.

What this interaction means in plain words

Eliglustat and Terbinafine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Eliglustat belongs to Miscellaneous; Terbinafine belongs to Anti Fungals.

Evidence level: Moderate

Why it happens

Terbinafine inhibits CYP2D6, markedly increasing eliglustat exposure.

What to do

Reduce eliglustat to the labeled lower dose in extensive metabolizers and monitor ECG; avoid it if other CYP3A inhibitors are also used.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Terbinafine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Terbinafine?

MediHelp rates the interaction as major. Eliglustat and Terbinafine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Eliglustat is mainly metabolized by CYP2D6, and terbinafine strongly inhibits it. Raised eliglustat levels may prolong PR, QRS and QT intervals and cause arrhythmia.

How serious is the interaction between Eliglustat and Terbinafine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce eliglustat to the labeled lower dose in extensive metabolizers and monitor ECG; avoid it if other CYP3A inhibitors are also used.

What other medicines interact with Terbinafine?

MediHelp also lists interactions of Terbinafine with, for example, Thioridazine, Desipramine, Flecainide. The full list is on the Terbinafine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in